BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 16770244)

  • 1. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
    Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
    Dresske B; Zavazava N; Jenisch S; Exner B; Lenz P; El Mokhtari NE; Kremer B; Faendrich F
    Transplantation; 2003 Apr; 75(8):1286-91. PubMed ID: 12717217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
    Alloway RR; Hanaway MJ; Trofe J; Boardman R; Rogers CC; Hanaway MJ; Buell JF; Munda R; Alexander JW; Thomas MJ; Roy-Chaudhury P; Cardi M; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):802-3. PubMed ID: 15848537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients.
    San Segundo D; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Benito MJ; Arias M; López-Hoyos M
    Clin Transplant; 2010; 24(3):386-93. PubMed ID: 19744094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
    Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
    Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.
    Donckier V; Craciun L; Lucidi V; Buggenhout A; Troisi R; Rogiers X; Boon N; Gustot T; Moreno C; Bourgeois N; Colle I; Van Vlierberghe H; Nagy N; Praet M; Dernies T; Amrani M; Stordeur P; de Hemptinne B; Goldman M
    Transplantation; 2009 May; 87(9 Suppl):S91-5. PubMed ID: 19424019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
    Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals.
    Moraes-Vieira PM; Silva HM; Takenaka MC; Monteiro SM; Lemos F; Saitovitch D; Kalil J; Coelho V
    Hum Immunol; 2010 May; 71(5):442-50. PubMed ID: 20122976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CD4+CD25+ T cells involved in induction of rat corneal allograft immune tolerance].
    Xi J; Pan ZQ; Jie Y; Liu LM; Wang L
    Zhonghua Yan Ke Za Zhi; 2007 Dec; 43(12):1114-8. PubMed ID: 18331683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
    Chavez H; Beaudreuil S; Abbed K; Taoufic Y; Kriaa F; Charpentier B; Durrbach A
    Transpl Immunol; 2007 Jun; 17(4):243-8. PubMed ID: 17493526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical rejection and persistent immune regulation in kidney transplant patients.
    Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
    Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.